Ketoconazole treatment of gonadotropin independent precocious puberty in girls with McCune-albright syndrome: A preliminary report

Journal of Pediatric Endocrinology and Metabolism

Volumn 12, Issue 1, 1999, Pages 81-83

  Syed, Farah Ali ^a   Chalew, Stuart A ^a,b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; KETOCONAZOLE; LUTEINIZING HORMONE; TESTOLACTONE;

ALBRIGHT SYNDROME; ARTICLE; BODY HEIGHT; BONE AGE; BONE GROWTH; CASE REPORT; CHILD; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; OVARY CYST; PRECOCIOUS PUBERTY; PRURITUS; REMISSION;

EID: 0032936389     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1999.12.1.81     Document Type: Article

References (13)

1. Mauras N, Blizzard RM. The McCune Albright syndrome. Acta Endocrinol 1986; 279 (Suppl): 207-217.
2. Wheeler MD, Styne DM. Diagnosis and management of precocious puberty. Pediatr Clin N Am 1990; 37: 1255-1271.
3. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegal AM. Activating mutations of the stimulatory G protein in the McCune Albright syndrome. N Engl J Med 1991; 325: 1688-1695.
4. Ringel MD, Schwindinger WF, Levine MA. Clinical implications of genetic defects in G proteins. The molecular basis of McCune Albright and Albright hereditary osteodystrophy. Medicine 1996; 75: 171-184.
5. Foster CM, Ross JL, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB Jr, Comite F. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 1984; 58: 1161-1165.
6. Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB Jr. Variable response to a long-acting agonist of lutenizing hormone releasing hormone in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 1984; 59: 801-805.
7. Wheeler MD. Update on therapy for precocious puberty. Compr Ther 1994; 20: 351-355.
8. Feuillan PP, Jones J, Cutler GB Jr. Long term Testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 1993; 74: 647-651.
9. Holland FJ, Fishman L, Bailey JD, Fazekas AT. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med 1985; 312; 1023-1028.
10. Holland FJ, Kirsch SE, Selby R. Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole. J Clin Endocrinol Metab 1987; 64: 328-333.
11. Holland FJ. Gonadotropin-independent precocious puberty. Endocrinol Metab Clin N Am 1991; 20: 191-210.
12. Yano K, Hidaka A, Saji M, Polymeropoulos MH, Okuno A, Kohn LD, Cutler GB Jr. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in lutieinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab 1994; 79: 1818-1823.
13. DiMattina M, Maronian N, Ashby H, Loriaux DL, Albertson BD. Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. Fertil Steril 1988; 49: 62-65.